Point of Care Testing or POCT can be described as a medically indicative testing performed outside the clinical lab in close vicinity to where the patient is getting care. POCT is typically performed by non-laboratory workers and the outcomes are utilized for decision
CASE STUDY TESTING FOR CHLAMYDIA 5 making in a clinical setting (Chernesky, Jang, & Krepel, 1999). There is a wide range of POCT techniques ranging from manual procedures to mechanized analyzers. POCT equipment are often 'hand held' or portable devices. With such advancement, medical practitioners no longer have to wait hours to get laboratory results. The emerging utilization of point of care testing devices makes it possible for providers to have prompt access to critical data regarding their patients (Chernesky, Jang, & Krepel, 1999). Disease Prevalance Since chlamydia is harder to diagnose in men than it is in women, due to the fact that there are no readily visible side effects in men, the fact of the matter is that women more susceptible to interacting with it (Johnson, 2002). In addition, studies show that more men that women, have multiple partners, thereby putting more women at risk. As such, just by share statistical numbers, the prevalence of the disease is more likely to be higher in women than it is in men. All positive screening test should be viewed as hypothetical proof of contamination. An extra test should be considered after a positive screening test if a false positive screening test would bring about generous unfriendly restorative social mental effect for a patient (Bailey, 2013). Urethral Swabs vs. Endocervical Swabs The use of endocervical swabs, vaginal swabs and pee are all examples for testing used for women. The results obtained from each of these testing examples may differ based on the populace tried and research facility technique utilized. A few research facility strategies are
CASE STUDY TESTING FOR CHLAMYDIA 6 accessible for direct recognition of chlamydia trachomatis, for example, cell society, immunofluorescense microscopy and chemical immunoassays. At present, nucleic corrosive enhancement tests give magnificent affectability and high specificity when connected on cervical and urethral swabs and male pee tests (Chernesky, Jang, & Krepel, 1999). This study
You've reached the end of your free preview.
Want to read all 8 pages?
- Spring '16
- Chlamydia infection, Pelvic inflammatory disease, Chlamydia trachomatis infection, CASE STUDY TESTING